Status:
COMPLETED
Lung Ultrasound to Guide Surfactant Therapy
Lead Sponsor:
Institut Investigacio Sanitaria Pere Virgili
Conditions:
Respiratory Distress Syndrome
Eligibility:
All Genders
24-32 years
Phase:
NA
Brief Summary
Inclusion criteria are premature newborns under the gestational age (GA) of 32 weeks old with RDS, defined as the need of non invasive mechanical ventilation to keep peripheral oxygen saturation (SpO2...
Detailed Description
Inclusion criteria are premature newborns under the gestational age (GA) of 32 weeks old with RDS, defined as the need of non invasive mechanical ventilation to keep peripheral oxygen saturation (SpO2...
Eligibility Criteria
Inclusion
- premature newborns under the gestational age (GA) of 32 weeks old with respiratory distress syndrome
Exclusion
- non-acceptance of the informed consent, chromosomal abnormalities, complex congenital malformations, signs of congenital septic shock and mechanical ventilation or endotracheal surfactant prior to the ultrasoundLUS
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04330443
Start Date
March 1 2019
End Date
May 10 2020
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Joan XXIII
Tarragona, Spain